Biden Calls On Private Businesses To ‘Require’ Employee Vaccination

Now that Pfizer’s COVID-19 vaccine has been approved by the US FDA, the president said there’s no reason why private companies cannot mandate vaccination of their employees.

U.S. President Joe Biden talks about COVID-19 response and vaccination at the Eisenhower Executive Office Building in Washington, DC, on 23 August, 2021
President Biden talks about COVID-19 response and vaccination at the Eisenhower Executive Office Building in Washington, DC, on 23 August • Source: Alamy

US President Joe Biden told private businesses to mandate COVID-19 vaccines in the workplace after the Food and Drug Administration announced it had approved Pfizer Inc. and BioNTech SE’s coronavirus vaccine. He argued that those who hesitated from putting in place such requirements because the vaccine had not been fully approved no longer have that excuse.

“Today I'm calling on more companies in the private sector to step up the vaccine requirements that will reach millions...

Medtech Insight Podcast

Keep up with the top medtech business and regulatory news.

Medtech Insight brings you interviews and analysis, on the go.

More from Compliance

MI-PolicyAndRegulation (Free-1): Biliary Atresia Linked to Autism and Neurodevelopment Delays

 
• By 

Children with biliary atresia (BA) exhibited neurodevelopmental deficits and increased autism traits, with earlier surgery linked to better general neurodevelopment.

Global Medtech Guidance Tracker: September 2024

 
• By 

Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Over 40 documents have been posted on the tracker since its last update.

Global Medtech Guidance Tracker: September 2024

 
• By 

Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Over 40 documents have been posted on the tracker since its last update.

Updated Notified Body Conduct Code Explains Permitted Structured Dialogue

There is considerable focus at present on how far notified bodies can go in helping position their clients to have as smooth a conformity assessment passage as possible. It is a fine balancing act for all involved, but a new document sheds some useful light.

More from Policy & Regulation

News We’re Watching: New FDA Approvals For Breast Implant, Colon Cancer Test, Imaging Agent; TAP Expansion, AI Standards

This week, Establishment Labs Holdings announced the FDA gave it premarket approval for Motiva breast implant, Cologuard lands FDA approval for Cologuard Plus and GE HealthCare gets FDA nod for a new imaging agent. The FDA announces another expansion for TAP into ophthalmology and radiology. The AAMI and CTA will join forces to develop standards for AI and ML-enabled health care products.  

MI-PolicyAndRegulation (Free-1): Biliary Atresia Linked to Autism and Neurodevelopment Delays

 
• By 

Children with biliary atresia (BA) exhibited neurodevelopmental deficits and increased autism traits, with earlier surgery linked to better general neurodevelopment.

Sponsored By

Nancy Tests SPARC-931 Part 7

This is a description